Document Classification

Section Type: RESULTS

Text: After the 6-month treatment and 12-month follow-up, there were significant differences between the trial and control group in the following : frequency of acute exacerbation (FAS : P = 0. 000 ; PPS : P = 0. 000) ; duration of acute exacerbation (FAS : P = 0. 000 ; PPS : P = 0. 001) ; FEV1 (FAS : P = 0. 007 ; PPS : P = 0. 008) ; symptoms (FAS : P = 0. 001 ; PPS : P = 0. 001) ; 6MWD (FAS : P = 0. 045 ; PPS : P = 0. 042) ; dyspnea scale (FAS : P = 0. 002 ; PPS : P = 0. 004) ; and physical domain (FAS : P = 0. 000 ; PPS : P = 0. 000), psychological domain (FAS : P = 0. 008 ; PPS : P = 0. 011), social domain (FAS : P = 0. 001 ; PPS : P = 0. 000) and environment domain (FAS : P = 0. 015 ; PPS : P = 0. 009) of the WHOQOL-BREF questionnaire.